Richard Kevin

@ACTINOSProject @sutcliffeob @CanTESTCBR @KnowYourStuffNZ Apologies David, no malice here! This interview was done with a larger press conference where @CanTESTCBR was mentioned several times. Just wanted to convey that this is proven tech, used worldwide. I'm a big admirer of the amazing work CanTEST is doing, hope no hard feelings!

@sutcliffeob @CanTESTCBR @KnowYourStuffNZ Oh, there’s not a bunch of ‘behind the press release’ journalism in Australia… It’s obviously a little entertaining that @CanTESTCBR didn’t get a mention in the interview, but if they did, it’d be less of a ‘news story’. Everyone deserves their moment in the Sun ☀️…

The FTIR is used much closer to home than the 'the UK'. It's the weapon of choice for both @CanTESTCBR & @KnowYourStuffNZ. But I'd guess that our chemistry friend already knows that...😀 abc.net.au/news/2023-09-1…

Huge thanks to my wonderful Lambert colleagues @EA_Cairns @AdamAmetovski @eric_sparkes @DuckyMcCartney @MA_BEDOYAPEREZ @JonathonCArnold @iainsmcgregor & many others for their support over the years <3

I'll be expanding out beyond the wonderful world of cannabinoids and will be working on all manner of things in the therapeutic drug monitoring space. Lots of hplc, mass spec, and clinical trials to come!

Today is my last day at the @Lambert_Usyd and @Sydney_Uni. Very sad to be leaving my many amazing colleagues but excited to take up a Senior Scientist position at @SVHSydney with @osbornidayius and co in their Clinical Pharmacology and Toxicology department!

So where does this leave us? Many more targets to look at (ion channels?) but for now - and perhaps expectedly - CB1 reigns supreme. Huge thanks to co-authors @EA_Cairns, @StinkyWinky, @BowenLabTweets, @JonathonCArnold, @iainsmcgregor, and @samuel_b_phd

The SCRAs tested hit quite a few GPCRs! But none of these off-target effects were at relevant concentrations or at targets that could explain the toxicity. Instead, AMB-FUBINACA produced CB1-dependent signaling disruption – pointing to on-target rather than off-target toxicity

Our new study out today: frontiersin.org/articles/10.33… In an attempt to characterise what might be contributing to the reported toxicity of some potent synthetic cannabinoids (SCRAs), we did a giant screen to look for off-target effects. The answer …

Our latest paper from @Lambert_Usyd on 4-fluoro and 4-cyanobutyl substituted synthetic cannabinoids is online today! tl;dr: most compounds assayed were moderate to high potency and efficacy CB1 agonists, and should be monitored as emerging NPS 🧪🔍 frontiersin.org/articles/10.33…

📣Free cannabis testing for ACT home-growers 🌿@Lambert_Usyd has launched its flagship CAN-ACT study of home-grown #cannabis in the ACT for medicinal and non-medicinal purposes. ➡️Read more: bit.ly/3dgIwyY #leadershipinaction #cannabismedicinal

@DuckyMcCartney “There is limited evidence to support the assertion that THC produces next-day impairment in driving” #ICADTS #T2022 Very substantial work conducted that was summarised very clearly and concisely @Lambert_Usyd

Checking my email every morning #AcademicTwitter

🚨 Our new paper on #CBD and driving is out! Doses of up to 1500mg of oral CBD does not impair simulated driving or cognitive performance in humans. 🙌 @DuckyMcCartney, @AnastasiaSuraev, Peter Doohan, @irwin_cg, @RichardKevinPhD, Prof Grunstein, @HoyosCamilla, @iainsmcgregor

Putative SCs MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T-Type Calcium Channel (CaV3) Inhibitors pubs.acs.org/doi/10.1021/ac… Cool work reporting more (non)-SCRA as modulators of T-type Ca channels ... plenty of potential in a number of different disease states 1/4

#THC in blood & saliva are poor indicators of #cannabis-induced impairment... ...found our latest study analysing all available studies. Led by @DuckyMcCartney, w/ @thomasarkell6 @irwin_cg @RichardKevinPhD @iainsmcgregor @BrainMind_Usyd @UsydPsych sydney.edu.au/news-opinion/n…

Interested in #NPS? and #harmreduction ? Come and do a PhD with me! (and @AmyKPeacock and @monicabarratt and Rachel Sutherland). You don't even move to Tassie (but you *could*). Ignore the closing date. Please RT! utas.edu.au/our-research/r…

#icrs2021 day 2. Late breaking research submission - Multiple overnight virtual conference attendance significantly increases snacking amongst academics. We’re (@Lambert_Usyd) on Twitter again, for all your questions 👩‍🔬🧑‍🔬👨‍🔬

Don't miss out on the Lambert Initiative cannabinoid research showcase at #ICRS2021! Oral presentations: @JonathonCArnold @TheCannabisGuyy @RichardKevinPhD Posters: @samuel_b_phd @EA_Cairns @DuckyMcCartney @JackMarkhamPhD Ayshe Sahinovic & @eric_sparkes new.icrs.co/ICRS2021/ICRS2…